Muscle and fat composition in patients with newly diagnosed multiple myeloma - Top-Institutions - MDSpire

Muscle and fat composition in patients with newly diagnosed multiple myeloma

  • By

  • Nadine H. Abdallah

  • Hiroki Nagayama

  • Naoki Takahashi

  • Wilson Gonsalves

  • Amie Fonder

  • Angela Dispenzieri

  • David Dingli

  • Francis K. Buadi

  • Martha Q. Lacy

  • Miriam Hobbs

  • Morie A. Gertz

  • Moritz Binder

  • Prashant Kapoor

  • Rahma Warsame

  • Suzanne R. Hayman

  • Taxiarchis Kourelis

  • Yi L. Hwa

  • Yi Lin

  • Robert A. Kyle

  • S. Vincent Rajkumar

  • Stephen M. Broski

  • Shaji K. Kumar

  • December 12, 2023

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Radiology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Radiology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Radiology

  • #4

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Radiology

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Hematology
    • Oncology
    • Radiology

Original Source(s)

Muscle and fat composition in patients with newly diagnosed multiple myeloma

  • by Nadine H. Abdallah, Hiroki Nagayama, Naoki Takahashi, Wilson Gonsalves, Amie Fonder, Angela Dispenzieri, David Dingli, Francis K. Buadi, Martha Q. Lacy, Miriam Hobbs, Morie A. Gertz, Moritz Binder, Prashant Kapoor, Rahma Warsame, Suzanne R. Hayman, Taxiarchis Kourelis, Yi L. Hwa, Yi Lin, Robert A. Kyle, S. Vincent Rajkumar, Stephen M. Broski, Shaji K. Kumar

  • December 12, 2023

Related Content

Exploring the Therapeutic Promise of γδ T Cells in Blood Disorders: Bridging Immunobiology and Clinical Innovation

Patient Awareness, Attitudes, and Preventive Practices Related to Venous Thromboembolism in Multiple Myeloma: A Cross-Sectional Analysis

Association of genetic ancestry with outcomes and toxicity of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma